FDA Drug Recalls

Recalls / Class II

Class IID-1339-2022

Product

Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS, UPC Code 641378938375.

Affected lot / code info
Lot# C07172101, Exp date: 07/2024; 2022054, Exp date: 03/2025

Why it was recalled

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Recalling firm

Firm
Loud Muscle Science
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
300 Oser Ave, N/A, Hauppauge, New York 11788-3608

Distribution

Quantity
2,495 60-count bottles
Distribution pattern
The product was distributed nationwide in the USA and Canada.

Timeline

Recall initiated
2022-06-27
FDA classified
2022-08-15
Posted by FDA
2022-07-27
Terminated
2023-02-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1339-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls